Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-21 Sale | 2025-08-22 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 50,000 | $14.49 | $724,345 | 11,303,141 (Indirect) | View |
| 2025-08-21 Sale | 2025-08-22 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 12,500 | $15 | $187,500 | 758,122 (Indirect Direct) | View |
| 2025-08-19 Sale | 2025-08-21 5:36 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 50,000 | $14.08 | $703,755 | 11,353,141 (Indirect) | View |
| 2025-07-01 Sale | 2025-07-03 4:21 pm | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 15,000 | $16.99 | $254,861 | 554,903 (Direct) | View |
| 2025-06-27 Sale | 2025-07-01 4:42 pm | ARS Pharmaceuticals Inc. | SPRY | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. 10% Owner | 740,149 | $18.46 | $13,663,151 | 4,887,254 (Indirect) | View |
| 2025-06-18 Sale | 2025-06-20 6:38 pm | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 15,000 | $16 | $240,000 | 567,284 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 5:00 pm | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 102,969 | $14.1 | $1,451,513 | 289,613 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 5:00 pm | ARS Pharmaceuticals Inc. | SPRY | SAUNDERS BRENT L Director | 120,000 | $14.25 | $1,710,024 | 470,950 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 5:00 pm | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 50,000 | $14.1 | $705,165 | 768,004 (Indirect Direct) | View |
| 2025-04-07 Sale | 2025-04-08 4:45 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,002 | $12.3 | $615,075 | 285,963 (Direct) | View |
| 2025-03-20 Sale | 2025-03-21 6:30 pm | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $14 | $140,000 | 582,284 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 5:12 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $11.21 | $560,446 | 408,074 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 4:35 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $12.31 | $615,565 | 334,410 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 6:24 pm | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $11.1 | $555,065 | 219,410 (Direct) | View |
| 2024-12-17 Sale | 2024-12-19 4:20 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $11.67 | $1,167,100 | 10,105,694 (Indirect Direct) | View |
| 2024-12-17 Sale | 2024-12-19 4:20 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $11.67 | $1,167,100 | 10,105,694 (Indirect Direct) | View |
| 2024-12-12 Sale | 2024-12-13 7:53 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,605 | $12.23 | $1,768,093 | 310,888 (Direct) | View |
| 2024-12-11 Sale | 2024-12-13 7:52 pm | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 40,000 | $12.35 | $493,859 | 74,680 (Direct) | View |
| 2024-12-10 Sale | 2024-12-12 5:41 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $13.15 | $657,625 | 136,380 (Direct) | View |
| 2024-12-10 Sale | 2024-12-11 6:30 pm | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 100,000 | $13.16 | $1,316,420 | 10,256,647 (Indirect Direct) | View |
| 2024-12-10 Sale | 2024-12-11 6:30 pm | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 100,000 | $13.16 | $1,316,420 | 10,256,647 (Indirect Direct) | View |
| 2024-12-04 Sale | 2024-12-06 7:15 pm | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $14.11 | $2,041,200 | 436,020 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-21 Exercise | 2025-08-22 4:30 pm | N/A 2032-02-29 | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 12,500 | $0 | 758,122 (Direct) | View |
| 2025-08-21 Exercise | 2025-08-22 4:30 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 12,500 | $1.5 | 758,122 (Direct) | View |
| 2025-07-01 Exercise | 2025-07-03 4:21 pm | N/A 2032-05-23 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 15,000 | $0 | 554,903 (Direct) | View |
| 2025-07-01 Exercise | 2025-07-03 4:21 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 15,000 | $1.5 | 554,903 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 5:21 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 30,000 | $0 | 30,000 (Indirect) | View |
| 2025-06-25 Option Award | 2025-06-27 4:43 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | Dadoo Rajeev Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:30 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:30 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | Kelly Michael Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:30 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | Islam Saqib Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:30 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:30 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | SAUNDERS BRENT L Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:30 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | SCHNEIDER PHILLIP M Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-27 4:30 pm | N/A 2035-06-24 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-06-18 Exercise | 2025-06-20 6:38 pm | N/A 2032-05-23 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 15,000 | $0 | 567,284 (Direct) | View |
| 2025-06-18 Exercise | 2025-06-20 6:38 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 15,000 | $1.5 | 567,284 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 5:00 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 100,000 | $0 | 289,613 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 5:00 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 100,000 | $5.58 | 289,613 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 5:00 pm | N/A 2031-06-15 | ARS Pharmaceuticals Inc. | SPRY | SAUNDERS BRENT L Director | 120,000 | $0 | 470,950 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 5:00 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | SAUNDERS BRENT L Director | 120,000 | $1.01 | 470,950 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 5:00 pm | N/A 2032-02-29 | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 50,000 | $0 | 768,004 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 5:00 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 50,000 | $1.5 | 768,004 (Direct) | View |
| 2025-04-07 Exercise | 2025-04-08 4:45 pm | N/A 2032-01-31 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,002 | $0 | 285,963 (Direct) | View |
| 2025-04-07 Exercise | 2025-04-08 4:45 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,002 | $4.85 | 285,963 (Direct) | View |
| 2025-03-20 Exercise | 2025-03-21 6:30 pm | N/A 2032-05-23 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $0 | 582,284 (Direct) | View |
| 2025-03-20 Exercise | 2025-03-21 6:30 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $1.5 | 582,284 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:12 pm | N/A 2032-01-31 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $0 | 408,074 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:12 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $4.85 | 408,074 (Direct) | View |
| 2025-02-03 Exercise | 2025-02-04 4:35 pm | N/A 2032-05-01 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $0 | 334,410 (Direct) | View |
| 2025-02-03 Exercise | 2025-02-04 4:35 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 9,064 | $3.15 | 334,410 (Direct) | View |
| 2025-02-03 Exercise | 2025-02-04 4:35 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 40,936 | $4.85 | 334,410 (Direct) | View |
| 2025-01-06 Exercise | 2025-01-07 6:24 pm | N/A 2032-05-01 | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $0 | 219,410 (Direct) | View |
| 2025-01-06 Exercise | 2025-01-07 6:24 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director | 50,000 | $3.15 | 219,410 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 152,300 | $0 | 152,300 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 261,900 | $0 | 261,900 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 1,029,500 | $0 | 1,029,500 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 1,029,500 | $0 | 1,029,500 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 274,100 | $0 | 274,100 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer | 176,700 | $0 | 176,700 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 152,300 | $0 | 152,300 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-13 7:53 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,605 | $0 | 310,888 (Direct) | View |
| 2024-12-12 Exercise | 2024-12-13 7:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 117,333 | $0.84 | 310,888 (Direct) | View |
| 2024-12-13 Exercise | 2024-12-13 7:53 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 27,272 | $1.44 | 310,888 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 7:52 pm | N/A 2028-11-28 | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 40,000 | $0 | 74,680 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 7:52 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer | 40,000 | $0.64 | 74,680 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:41 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $0 | 136,380 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:41 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 50,000 | $0.84 | 136,380 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:43 pm | N/A 2031-12-13 | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 37,541 | $0 | 13,050,073 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:43 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 13,789 | $1.44 | 13,050,073 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:43 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner | 11,876 | $8.42 | 13,050,073 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:25 pm | N/A 2033-01-02 | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 37,541 | $0 | 13,050,073 (Direct) | View |
| 2024-12-06 Exercise | 2024-12-09 5:25 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 13,789 | $1.44 | 13,050,073 (Indirect) | View |
| 2024-12-06 Exercise | 2024-12-09 5:25 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner | 11,876 | $8.42 | 13,050,073 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 7:15 pm | N/A 2029-07-04 | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $0 | 436,020 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 7:15 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer | 144,640 | $0.84 | 436,020 (Direct) | View |